What question did this study set out to answer?

To evaluate and compare the endothelial toxicity profiles of conventional anthracyclines and pegylated liposomal doxorubicin in human coronary artery endothelial cells.

January 1, 2004Endothelium

Differential Toxicity of Anthracyclines on Cultured Endothelial Cells

View Full Paper

Ask AI

Bookmark

Why the study?

Does pegylated liposomal doxorubicin prevent endothelial toxicity compared to doxorubicin and its analogs in human coronary artery endothelial cells?

Key Points

To evaluate and compare the endothelial toxicity profiles of conventional anthracyclines and pegylated liposomal doxorubicin in human coronary artery endothelial cells.
Treated cultured human coronary artery endothelial cells (HCAECs) with doxorubicin, daunorubicin, idarubicin, or pegylated liposomal doxorubicin (doxil).
Evaluated endothelial cell viability, caspase-3 apoptotic activity, and Western blot expression levels of Bcl-2, Bax, phospho-Akt, Mcl-1, and p53.
Endothelial viability was maintained following doxil exposure, whereas doxorubicin, daunorubicin, and idarubicin significantly decreased viability and elevated caspase-3 activity.
Mcl-1 protein expression remained unaltered with doxil but significantly decreased with conventional anthracyclines; p53 was markedly induced by traditional anthracyclines but minimally affected by doxil.

Structured PICO

Does pegylated liposomal doxorubicin prevent endothelial toxicity compared to doxorubicin and its analogs in human coronary artery endothelial cells?

Population

human coronary artery endothelial cells (HCAECs)

Intervention

pegylated liposomal doxorubicin

Comparator

doxorubicin, daunorubicin, and idarubicin

Outcome

Endothelial viabilitysurrogate

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

Pegylated liposomal doxorubicin appears to protect endothelial cells from anthracycline-induced injury by preventing caspase-3 activation and maintaining Mcl-1 expression.

Cite This Study

Kaushal et al. (2004) studied this question.

synapsesocial.com/papers/6a796a2702ab7a73dd025590 https://doi.org/10.1080/10623320490904124

Topics

Bremelanotide

View Full Paper

Ask AI

Bookmark

Implication

Pegylated liposomal doxorubicin appears to protect endothelial cells from anthracycline-induced injury by preventing caspase-3 activation and maintaining Mcl-1 expression.

Differential Toxicity of Anthracyclines on Cultured Endothelial Cells

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Topics

Differential Toxicity of Anthracyclines on Cultured Endothelial Cells

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Topics

Also Consider